MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Vietnam. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

Fact Sheet: Investing in Sexual and Reproductive Health in Asia. UNFPA and Guttmacher Institute. (2014)

immage

Sexual and reproductive health services enable women and couples to have the number of children they want, when they want them; to deliver their babies safely and have healthy newborns; and to have healthy sexual lives, free from HIV and other sexually transmitted infections (STIs).

 

Keywords: HIV, maternal health, human rights, investments, cost-effectiveness

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Bangladesh. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

Meeting Report: Funding the trans HIV Response Meeting of Trans Activists, Donors, and other Key Stakeholders. amfAR, Global Action for Trans Equality, International Reference Group on Trans and Gender Variant Communities and HIV/AIDS, et al. (2014)

immage

Objectives for the meeting included:

• Highlighting existing data on the state of the trans* movement and the level of current investments by GFATM, PEPFAR, and other funders for HIV-focused trans* service delivery, advocacy, and research efforts at the local and national levels.
• Identifying opportunities and barriers for trans* organizations and communities participation in the country dialogue process of GFATM’s and PEPFAR’s country operational plans Strategizing about short-term and medium-term concrete actions that trans* activists, GFATM and PEPFAR representatives, and other stakeholders can take to increase trans* engagement in GFATM and PEPFAR funding processes
• Establishing mechanisms for ongoing dialogue between trans* activists and representatives from GFATM and PEPFAR.


Keywords: key Populations, LGBT, transgender, Thailand 

Download Publication

Transition Manual for the New Funding Model of the Global Fund. The Global Fund. (2013)

Core New_Funding_Model_Transition_Manual_2013-1

The Global Fund is changing its funding model. The new model will change the way the Global Fund assesses, approves, disburses, and monitors grants to increase successful applications, improve implementation, and ultimately achieve greater impact. The new model will increase engagement between applicants and the Global Fund and provide implementers with more flexibility, predictability, and clarity. 

 

Download this publication

New Funding Model Overview. The Global Fund. (2013)

Core New_Funding_Model_Overview_2013-1

The new model provides implementers with more flexible timing, better alignment with national strategies and greater predictability on the level of funding available. There is more active engagement with implementers and partners throughout grant application and implementation to ensure greater global impact. 

 

 

Download this publication

Countries Participating in the New Funding Model. The Global Fund (2013)

Core NewFundingModelCountries2013_List_en-1

Six countries and three regional programs are being invited as early applicants to participate in the full process of the new funding model, from submitting a concept note to creating a new grant. The countries – Zimbabwe, El Salvador, Myanmar, the Democratic Republic of the Congo, Kazakhstan and the Philippines – will be able to access a total of US$364 million in new funding in the transition period. They can also apply for additional funds that incentivize ambitious and high impact investments and co-financing. 

 

Download this publication

The New Funding Model - Key Features and Implementation. The Global Fund. (2013)

Core New_Funding_Model_Presentation_2013-1

Principles of the new funding model

•  Greater alignment with country schedules, context, and priorities 

•  Focus on countries with the highest disease burden and lowest ability to pay, while keeping the portfolio global 

•  Simplicity for both implementers and the Global Fund 

•  Predictability of process and financing levels 

•  Ability to elicit full expressions of demand and reward ambition

 

 

Download this publication

The New Funding Model Summary. The Global Fund. (2013)

Core New_Funding_Model_Summary_2013

A transition to the new funding model is underway. Access to funding in the transition phase is by invitation, and special consideration will be given to countries in a position to achieve rapid impact, those at risk of service interruptions, and those currently receiving less than they would under the new funding model’s allocation principles. There is diversity across regions and diseases and types of applicants, so that elements of the new funding model can be tested and refined. 

 

 

Download this publication

National AIDS Spending Assessment (NASA IV) in Cambodia: Years of Assessment: 2011 and 2012. Nitsoy A. (2013)

immage

NASA team always aims to collect expenditure data from all actors of the response. These organizations – actors of the HIV response – are playing different roles in different transactions, either financial or in-kind. The organization acts as a Financing Source when it makes money available for the country’s HIV response. It transfers funds to the other organizations who decide what should be implemented and who will be implementing. This role is a role of a Financing.

Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Jul
11
(11 Jul - 11 Jul)
Jul
28
(28 Jul - 28 Jul)